Page last updated: 2024-09-04

cinacalcet and Angina, Unstable

cinacalcet has been researched along with Angina, Unstable in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chertow, GM; Franchetti, Y; Liu, S; Long, J; Mahnken, JD; Nolin, TD; Prokopienko, AJ; Stedman, MR; Stubbs, JR; West, RE1
Abdalla, S; Chertow, GM; Montez-Rath, ME; Parfrey, PS1
Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER1

Trials

1 trial(s) available for cinacalcet and Angina, Unstable

ArticleYear
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, 02-07, Volume: 12, Issue:2

    Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate

2017

Other Studies

2 other study(ies) available for cinacalcet and Angina, Unstable

ArticleYear
Trimethylamine
    Clinical journal of the American Society of Nephrology : CJASN, 2019, 02-07, Volume: 14, Issue:2

    Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Female; Hospitalization; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Methylamines; Middle Aged; Mortality; Myocardial Infarction; Randomized Controlled Trials as Topic; Renal Dialysis; Stroke

2019
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
    Contemporary clinical trials, 2016, Volume: 48

    Topics: Aged; Angina, Unstable; Calcimimetic Agents; Cause of Death; Cinacalcet; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome

2016